参考文献/References:
[1]Ginsburg O,Bray F,Coleman MP,et al.The global burden of women’s cancers:a grand challenge in global health[J].Lancet,2017,389(10071):847-860. [2]Cheng Y,Yan Y,Gong J,et al.Trends in incidence and mortality of female breast cancer during transition in Central China[J].Cancer Manag Res,2018(10):6247-6255. [3]Rugo HS,Barry WT,Moreno-Aspitia A,et al.Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer:CALGB 40502/NCCTG N063H(Alliance)[J].J Clin Oncol,2015,33(21):2361-2369. [4]Chan CWH,Law BMH,So WKW,et al.Novel Strategies on Personalized Medicine for Breast Cancer Treatment:An Update[J].Int J Mol Sci,2017,18(11):2423. [5]Zhang X,Wang D,Li Z,et al.Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer[J].Front Immunol,2020(11):331. [6]Gradishar WJ,Anderson BO,Abraham J,et al.Breast Cancer,Version 3.2020,NCCN Clinical Practice Guidelines in Oncology[J].J Natl Compr Canc Netw,2020,18(4):452-478. [7]Parvizpour S,Razmara J,Omidi Y.Breast cancer vaccination comes to age:impacts of bioinformatics[J].Bioimpacts,2018,8(3):223-235. [8]Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249. [9]Hernandez RK,Wade SW,Reich A,et al.Incidence of bone metastases in patients with solid tumors:analysis of oncology electronic medical records in the United States[J].BMC Cancer,2018,18(1):44. [10]Wu Q,Li J,Zhu S,et al.Breast cancer subtypes predict the preferential site of distant metastases:a SEER based study[J].Oncotarget,2017,8(17):27990-27996. [11]Salamanna F,Borsari V,Contartese D,et al.What Is the Role of Interleukins in Breast Cancer Bone Metastases?A Systematic Review of Preclinical and Clinical Evidence[J].Cancers(Basel),2019,11(12):2018. [12]孙向飞,周喜春,陈小波.LIFR基因mRNA表达对乳腺癌患者预后的判断价值[J].海南医学,2020,31(23):3046-3050. [13]Johnson RW,Finger EC,Olcina MM,et al.Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow[J].Nat Cell Biol,2016,18(10):1078-1089. [14]Dear RF,McGeechan K,Jenkins MC,et al.Combination versus sequential single agent chemotherapy for metastatic breast cancer[J].Cochrane Database Syst Rev,2013(12):Cd008792. [15]Mukai H,Ito M.Advances in chemotherapy for HER2-negative metastatic breast cancer[J].Chin Clin Oncol,2018,7(3):26. [16]Ocana A,Hortobagyi GN,Esteva FJ.Concomitant versus sequential chemotherapy in the treatment of early-stage and metastatic breast cancer[J].Clin Breast Cancer,2006,6(6):495-504. [17]Albain KS,Nag SM,Calderillo-Ruiz G,et al.Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment[J].J Clin Oncol,2008,26(24):3950-3957. [18]Seidman AD,Brufsky A,Ansari RH,et al.Phase Ⅲ trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer[J].Ann Oncol,2011,22(5):1094-1101.
相似文献/References:
[1]彭玉龙,张 露,陈荣辉,等.吉西他滨与培美曲塞联合卡铂治疗晚期肺腺癌的临床观察[J].医学信息,2018,31(11):124.[doi:10.3969/j.issn.1006-1959.2018.11.039]
PENG Yu-long,ZHANG Lu,CHEN Rong-hui,et al.Clinical Observation of Gemcitabine and Pemetrexed Combined with Carboplatin in Treatment of Advanced Lung Adenocarcinoma[J].Medical Information,2018,31(14):124.[doi:10.3969/j.issn.1006-1959.2018.11.039]
[2]张晓玲.替吉奥联合多西他赛治疗转移性乳腺癌的临床疗效观察[J].医学信息,2018,31(20):128.[doi:10.3969/j.issn.1006-1959.2018.20.038]
ZHANG Xiao-ling.Clinical Observation of Tegafur,Gimeracil and Oteracil Porassium Capsules Combined with Docetaxel in the Treatment of Metastatic Breast Cancer[J].Medical Information,2018,31(14):128.[doi:10.3969/j.issn.1006-1959.2018.20.038]
[3]刘 贝,郑 慧,周 旺,等.3D-STI联合心脏综合指数评价肺癌患者GP化疗方案的隐匿性心肌毒性[J].医学信息,2019,32(08):100.[doi:10.3969/j.issn.1006-1959.2019.08.029]
LIU Bei,ZHENG Hui,ZHOU Wang,et al.Evaluation of Occult Myocardial Toxicity in GP Chemotherapy Regimen of Lung Cancer Patients by 3D-STI Combined with Cardiac Comprehensive Index[J].Medical Information,2019,32(14):100.[doi:10.3969/j.issn.1006-1959.2019.08.029]
[4]苗培田.靶向药物赫赛汀治疗转移性乳腺癌的研究[J].医学信息,2019,32(09):45.[doi:10.3969/j.issn.1006-1959.2019.09.015]
MIAO Pei-tian.Targeted Drug Herceptin in the Treatment of Metastatic Breast Cancer[J].Medical Information,2019,32(14):45.[doi:10.3969/j.issn.1006-1959.2019.09.015]
[5]张书林,黄盛源,刘忠林,等.吉西他滨和多西他赛联合顺铂治疗晚期非小细胞肺鳞癌的效果比较[J].医学信息,2021,34(24):141.[doi:10.3969/j.issn.1006-1959.2021.24.036]
ZHANG Shu-lin,HUANG Sheng-yuan,LIU Zhong-lin,et al.Comparison of Gemcitabine and Docetaxel Combined with Cisplatin in the Treatment of Advanced Non-small Cell Lung Squamous Cell Carcinoma[J].Medical Information,2021,34(14):141.[doi:10.3969/j.issn.1006-1959.2021.24.036]
[6]李云霞,赵 玲,赵明利,等.奈达铂联合吉西他滨阻滞非霍奇金淋巴瘤细胞周期促进细胞凋亡的作用研究[J].医学信息,2022,35(08):61.[doi:10.3969/j.issn.1006-1959.2022.08.015]
LI Yun-xia,ZHAO Ling,ZHAO Ming-li,et al.Effect of Nedaplatin Combined with Gemcitabine on Cell Cycle Arrest and Apoptosis in Non-Hodgkin Lymphoma[J].Medical Information,2022,35(14):61.[doi:10.3969/j.issn.1006-1959.2022.08.015]